Figure 1 (Tocilizumab 01)
Tocilizumab-anoh Injection, Solution, Concentrate
Product Images NDC 72606-049
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 35 technical images submitted to the FDA as part of the official labeling for Tocilizumab-anoh (NDC 72606-049). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Celltrion Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 2 (Tocilizumab 02)
Figure A (Tocilizumab 03)
This text appears to be a list of items related to a medical device or tool. It includes terms such as "Plunger", "White", "Finger", "Flange", "Viewing", "Medicine Window", "Needle", "Guard", and "After Use". These items are likely components or features of a product that is used before and after use.*
Figure B (Tocilizumab 04)
A description of the contents of a medical kit which includes a carton with a prefilled syringe, cotton ball or gauze, alcohol swab, adhesive bandage, and a FDA-cleared sharps disposal container.*
Figure C (Tocilizumab 05)
Figure D (Tocilizumab 06)
Figure E (Tocilizumab 07)
Figure F (Tocilizumab 08)
Figure G (Tocilizumab 09)
Figure H (Tocilizumab 10)
Figure I (Tocilizumab 11)
Figure J (Tocilizumab 12)
Figure K (Tocilizumab 13)
Figure L (Tocilizumab 14)
Figure M (Tocilizumab 15)
Figure N (Tocilizumab 16)
Figure A (Tocilizumab 17)
This text provides instructions and details about a medical device before and after use. It includes information about an expiration date, an orange indicator to show that the injection is complete, and a blue needle cover that is locked with the needle inside after use. The text seems to be a label or guide for using the device safely and effectively.*
Figure B (Tocilizumab 18)
This text appears to be a list of the contents of a carton, which include cotton balls, an auto-injector, gauze, alcohol swab, adhesive bandage, and a sharps disposal container. The items mentioned seem to be for medical or health-related purposes.*
Figure C (Tocilizumab 19)
Figure D (Tocilizumab 20)
Figure E (Tocilizumab 21)
Figure F (Tocilizumab 22)
Figure G (Tocilizumab 23)
Figure H (Tocilizumab 24)
Figure I (Tocilizumab 25)
Figure J (Tocilizumab 26)
Figure K (Tocilizumab 27)
Figure L (Tocilizumab 28)
Figure M (Tocilizumab 29)
Figure N (Tocilizumab 30)
Figure O (Tocilizumab 31)
Principal Display Panel (80 mg/4 mL Vial Carton)
Principal Display Panel (200 mg/10 mL Vial Carton)
Principal Display Panel (400 mg/20 mL Vial Carton)
This is a description of Tocilizumab-anoh, an injection with a concentration of 400 mg/20 mL (20 mg/mL), intended for intravenous infusion after dilution. It comes in a single-dose vial which should be refrigerated at 2°C to 8°C (36°F to 46°F) to protect it from light. Each vial contains a solution with various components like tocilzumab-anoh, histidine, methionine, and more. The solution has a pH of 6.0 and does not contain any preservatives. The product is manufactured by CELLTRON, Inc in South Korea and distributed by CELLTRION USA, Inc in the USA. The dosage details are provided in the prescribing information.*
Principal Display Panel (162 mg/0.9 mL Autoinjector Carton)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
